- VinCense in BBC Click
- VinCense in the finals of Unnati - Sweden India Healthcare innovation Challange.
- MedIoTek in Digital Wellbeing Alliance
- IIT Madras creates history
- VinCense and Heart Rescue India Project
- WRCB Industry Day
- Avnet and MedIoTek
- Startup Stories
- European Respiratory Journal Publication
- Chennai View News
- Motorcycle Ambulances
- ABI Research
- Interview with STL partners,a leading UK based telco research company
- VinCense selected by Covid India Task force
- YourStory Research Report on H1 2020 Startup Funding
- VinCense associates with Chola MS Risk
- Your Story
- MedIoTek onboarded as digital partner in L&T infotech's IIoT platform
- MedIoTek C-CIDA coverage in the Hindu Businessline
- MedIoTek selected as Week 2 star in C-CAMP COVID-19 Deployment Accelerator (C-CIDA)
- VinCense featured in leading Tamil newschannel Malai murasu for its COVID19 risk screening capability
- VinCense COVID-19 Risk Detection Use case covered in the Hindu, Apr 6, 2020
- CII TN Medclave
- MoU with Velammal College of Engineering and Technology in Madurai.
- Medtech Health check
- VinCense partnership with Wipro GE Healthcare
- Healthcare Warrior award 2021 at World Health & Wellness congress
- VinCense featured as one of the top remote monitoring platforms in MRA report
VinCense one of the seven finalists in the Sweden India healthcare innovation challenge.
New Delhi: Leif Johansson, Chairman of the Board, AstraZeneca Plc during his three day visit to India, announced a mile-stone expansion of the company’s strategic collaborations to address the rising burden of Non-Communicable Diseases(NCDs) in India. The new partnerships with Indian and Swedish partners aspire to the ambitions of the India-Sweden Innovation Partnership for a Sustainable Future, as agreed upon last year by Indian Prime Minister Modi and Swedish Prime Minister Löfven.
At the India-Sweden Unnati healthcare 2.0 day, the company and its partners, Business Sweden, The National Association of Software and Services Companies (NASSCOM), Atal Innovation Mission-Niti Aayog and AGNIi, announced the finalists of the Unnati Healthcare Innovation Challenge. At the same time, AstraZeneca launched a strategic partnership with the NASSCOM IoT Centre of Excellence to set up an accelerator programme to support Indian start-ups develop new innovative solutions to NCD care in India and beyond.
Unnati is based on the spirit of India Sweden Joint Declaration on Innovation Partnership for Sustainable Future to create on-the-ground collaboration through user-case driven innovation challenges. As part of this challenge, 90+ healthcare start-ups participated from all over India. The finalists were invited to present their ideas at the Unnati Healthcare 2.0 day. The selected winners among the finalists will be receiving mentorship support from AstraZeneca, which will contribute its unique healthcare domain expertise with the aim of helping the finalists bring their solutions to market.
AstraZeneca also signed a Memorandum of Understanding with NASSCOM- Centre of Excellence, Internet of Things for a Health Tech Start-up Accelerator Programme and Incubation Centre in Bangalore. NASSCOM – CoE IoT was launched as part of Government of India’s Digital India Initiative to help the country achieve a leadership role in the convergent areas of hardware and software. Under this collaboration, AstraZeneca and NASSCOM will incubate start-ups in bringing innovative and frugal solutions that can help in the management of NCDs. Selected startups will have access to NASSCOM’s innovation labs, development resources, cloud services and mentoring support from NASSCOM and AstraZeneca including the opportunity to showcase their innovations in national and global platforms where the latter can showcase their products or services.
Commenting on these initiatives, Leif Johansson, Chairman of the Board, AstraZeneca PLC said, “As a science-led organisation, AstraZeneca is committed to strengthen innovation in healthcare in India. We are pleased to collaborate with the government, start-up eco-system and industry partners to achieve the shared vision of making meaningful interventions in improving the lives of patients impacted by Non-Communicable diseases in India.”
IIT Madras collaborates with Health Technology firms to make Chennai the ‘Digital Wellbeing Capital’ of the world
Indian Institute of Technology Madras (IIT Madras) is initiating an alliance called 'Digital Wellbeing Alliance' to deploy digital technologies with the objective of making Chennai the 'Digital Wellbeing Capital' of the world.
The Institute will use its expertise in Blockchain, Artificial Intelligence/Machine Learning, IoT and Motion Capture Technology to work for the wellbeing of the community, specifically the young workforce and weaker sections of the society.
The alliance was inaugurated today, Wednesday, July 4, 2018, at IIT Madras by Dr Ram D Sriram, a renowned AI and healthcare expert and is currently the chief of the Software and Systems Division, Information Technology Laboratory, at the National Institute of Standards and Technology (NIST), US federal government.
Speaking about the importance of this workshop, Prof M Manivannan, Biomedical Engineering Group, Department of Applied Mechanics, IIT Madras, who organized this alliance, said, "There are many issues that only an alliance can solve. We will brainstorm to identify those issues in this workshop. This alliance is spearheaded by several passionate people, apart from me, including Prof D Janakiram of IIT Madras, Sridharan Sivan of S10 Health Solutions, Sharmila Devadas of MedioTek Health Systems, Subbarao of Chola MS Risk, again emphasizing alliance of people rather than individuals.
The stakeholders of this alliance would be academic institutions such as all the IITs, Health technology companies, medical device makers, digital health players, medical institutions, corporate firms, Government bodies such as NITI Aayog and Certifying/Regulating agencies. The Global Alliance is an initiative of IIT Madras along with Industrial partners, hospitals, and global thought leaders.
This alliance is intended to improve quality of life for healthcare providers and seekers and to leverage India's strength to enhance global health and wellness care.
The alliance has its own blockchain which is a decentralized platform that enables secure, fast and transparent exchange and usage of medical data with smart contracts. With the blockchain technology, the community end user is at the centre of the digital transformation of healthcare and is empowered with the right of his/her own data.
The Wellbeing Paradigm will determine India's Gross domestic product (GDP) in the future. Wellbeing of a community, beyond eating healthy food and exercises, will be determined by many other factors.
This alliance would work to foster market-driven innovation, to enhance skill development, to protect intellectual property and develop best-in-class manufacturing infrastructure, spawn new products and services around Industry 4.0. This alliance enables cooperation of all stakeholders through blockchain for setting policy, standards and regulatory framework.
The focus would be on Culture of Wellbeing, Interoperability, Data privacy, Cyber security, Policy, Consumer engagement and Evidence and Evaluation. The alliance will be a great platform to drive the global penetration for the thriving health tech start-up community.
A workshop that followed the inaugural function included eminent speakers including Prof Amar Gupta from Massachusetts Institute of Technology (MIT), Dr Julian Goldman from Massachusetts General Hospital (MGH), Harvard Medical School, Dr Amit Sheth from Wright State University, Dr Soundar Kumara from Penn State University, and Prof D Janakiram, IIT Madras.
A panel discussion in the workshop will be moderated by Dr Vinod Abraham, professor and head of Community Health, CMC Vellore.
IIT Madras creates history! India’s 1st health monitoring wearable device is here
Prestigious Indian Institute of Technology (IIT) Madras has created a history by developing the algorithm for the country's first medical-grade, wearable device with algorithms for deriving vitals in a non-invasive manner.
It’s yet another feather in the cap of IIT Madras! Prestigious Indian Institute of Technology (IIT) Madras has created a history by developing the algorithm for the country’s first medical-grade, wearable device with algorithms for deriving vitals in a non-invasive manner. This device is called VinCense, and it is loaded with algorithms to derive vitals non-invasively and unobtrusive monitoring for effective healthcare delivery.
VinCense and Heart Rescue India Project
MedIoTek Health Systems participated in the annual meeting of Heart Rescue India - “Heart Rescue India Community Services Program” held at Ramaiah Medical College on 29th & 30th Oct 2017. Our MD, Ms. Sharmila Devadoss attended the program on behalf of our company. She has also been made a member of the advisory panel for Heart Rescue India.
M.S. Ramaiah Medical College, M.S. Ramaiah Memorial Hospital, MSR Advanced Learning Centre, University of Illinois at Chicago and Medtronic are the key partners in Heart Rescue India. The program is a first-of-its-kind, US$4.4 million collaborative effort funded by Medtronic Philanthropy that supports community-based demonstration projects designed to expand access to life-saving interventions for cardiovascular events such as heart attack and sudden cardiac arrest. http://www.heartrescueproject.com/heartrescue-project-partners/international-partners/heartrescue-global-india/
The plan is to work with local and national partners to design an integrated and scalable emergency response system using community health responders, 108 emergency dispatch, and designated hub and spoke hospitals by establishing help desks across the cities for risk screening. VinCense Health Screening Platform (www.vincense.com) that can measure pulse rate, oxygen saturation, respiratory rate, skin temperature, BP, blood glucose level and weight wirelessly and automatically, will be used in the help desks for risk screening the individuals visiting the hospitals. Besides, it also helps in maintaining a database registry for patients with cardiac diseases, so that the continuum of care is not lost. Particularly useful in the hub and spoke model and also useful for longitudinal studies to analyze the impact of Screening of NCDs.
The Annual Meeting saw a gathering of eminent doctors and specialists from various hospitals, Government of Karnataka, Civil Defence, Red Cross, NSS and schools in the vicinity. It included various sessions ranging from open house presentations to round table discussions focussing on risk screening and community and school outreach programs to create awareness towards cardiac diseases.
WRCB Industry Day
MedIoTek Health Systems participated at the 2nd edition of the Wadhwani Research Centre for Bioengineering (WRCB) annual Industry Day that was held at IIT Bombay on September 8, 2017 along with the other medical and healthcare leaders. Our Managing Director Ms. Sharmila Devadoss were among the panelists who provided their inputs on “Point of care and wearables Diagnostics - the next big wave”
The event saw a gathering of eminent people including innovators, industry experts, entrepreneurs, researchers, medical practitioners and government representatives who are focused on converting a proof-of-concept to a marketable product.
Besides MedIoTek, Abbott, AMTZ, Bio- Medicon Systems, Eisai Pharmaceuticals, Pulse Pharmaceuticals, Biopore Surgicals, Sree Chitra Tirunal Institute of Medical Science and Technology, SRL Diagnostics were some of the other participants at the event. The impact of point of care and wearables diagnostics in empowering the healthcare, elderly care and chronic disease management were discussed during a panel discussion.
The role of wearables and point of care devices in improving patient outcomes, early intervention of diseases and skill- infrastructure gaps were discussed. The wearables proves to be a great aid in care delivery in the socio economic angle perspective, which makes them suitable for use in low and middle income countries to provide high quality care delivery at an affordable cost which is difficult at present due to increased cost of care delivery, thus aiding in democratization of health care.
Avnet and MedIoTek to Transform Healthcare Delivery in India
Announce Joint Marketing Agreement
CHENNAI, INDIA, October 17, 2017 – Avnet (NYSE:AVT), a leading global technology distributor, and MedIoTek Health Systems, announce a joint marketing agreement to promote MedIoTek’s VinCense remote patient monitoring system. Under the agreement, Avnet will engage its broad network of key ecosystem suppliers and providers in the industry to help market MedIoTek products and solutions.
Advancements in technologies have stimulated the adoption of wearables devices in the healthcare industry. The VinCense system features a wearables that measures pulse rate, oxygen saturation, respiration rate and skin temperature, complemented by an application that sends out alerts to five pre-configured numbers if the vitals go out of range. A web-interface captures vital signs wirelessly and pushes into a secure cloud application.
MedloTek Health Systems, incorporated in 2016, is a unique startup that has leveraged technology to improve the quality of life for the masses. It has pioneered affordable medical care through an advanced remote patient monitoring platform integrating India’s first clinical grade wearables wireless health monitoring system – VinCense, providing efficient care for patients, unobtrusively and non-invasively.
“Considering the high cost of quality care today and its inaccessibility to the common man, we aim to transform and democratize healthcare delivery and management by developing mobile health technology that enables patients, senior citizens and persons suffering from chronic heart/lung diseases enjoy an improved quality of life at an affordable cost,” says Sharmila Devadoss, Founder and Managing Director. Sharmila has over two decades of experience at leading positions in various engineering and managerial roles. She has won many accolades for her achievements in domains such as digital health, embedded systems and semiconductor IP.
VinCense WHMS featured in European Respiratory Journal Publication
In the future, diagnostic devices will be able to monitor a patient’s physiological or biochemical parameters continuously, under natural physiological conditions and in any environment through wearables biomedical sensors. Together with apps that capture and interpret data, and integrated enterprise and cloud data repositories, the networks of wearables devices and body area networks will constitute the healthcare’s Internet of Things. In this review, four main areas of interest for respiratory healthcare are described: pulse oximetry, pulmonary ventilation, activity tracking and air quality assessment. Although several issues still need to be solved, smart wearables technologies will provide unique opportunities for the future or personalised respiratory medicine.
Have this on your wrist to keep off emergencies
Summary: The device, VinCense Wireless Health Monitoring System (WHMS) is essentially a gadget that is worn on the wrist. The wearables wrist device records the vital signs of the patient, and transfers it to a secure cloud application through internet. It will always help doctors and patients communicate well, despite geographical distances. To avoid such emergencies, the WHMS was created and launched,” Sharmila added.
CHENNAI: Medio Tek Health Systems has launched a device that may prove to be a game changer in the delivery of healthcare. The device, VinCense Wireless Health Monitoring System (WHMS) is essentially a gadget that is worn on the wrist. WHMS has three components: first being the physical device, second is an android application and the third is the web interface. The device wirelessly records parameters like Skin Temperature, pulse rate, blood pressure, Electrocardiogram (ECG), respiratory rate, blood glucose level etc.
The wearables wrist device records the vital signs of the patient, and transfers it to a secure cloud application through internet. The same can then be viewed by doctors, if and when they are allowed access. “If a patient is in pain, the device can also detect that, and also the degree of pain. If there is an emergency, an SMS alert will be sent to five configured numbers; it may be a doctor, a relative of the patient and or the ambulance service.
Chennai View News
Speaking to The Goan, a representative from the Bangalore-based company Bangalore Medical Systems Pvt Ltd (BMS) said the vehicle will prove to be of importance especially in a state like Goa. “So far this type of emergency service is found in states like Maharashtra and Karnataka, where it is doing a good job. Here in Goa too it will prove to be very important especially with narrow roads that make it difficult for a four-wheeled ambulance to rush to the spot of emergency,” he said. Sold under the RMS Motors tag, BMS has agreed to provide 22 motorcycle ambulances. On a pilot basis, BMS has delivered one ambulance to the state.
The motorcycle ambulance (150 cc bike) has a special box strapped to the back of the vehicle that contains the medical equipment. It contains an automated external defibrillator, a first-aid kit, an IV set, a wireless monitoring system along with oxygen cylinders, entonox cylinder (containing a mixture of medical nitrous oxide and oxygen). The first-aid kit contains a CPR mask, stethoscope, and laryngoscopes. The representative also said that people operating the service will be well trained. The ambulance on wheels is expected to reach the site of the emergency in a matter of five minutes and depending on the seriousness of the emergency, a 108 ambulance will be requisitioned.
Patient-monitoring wearables are steadily increasing in popularity, due to their ability to monitor health in real time continuously throughout the day, in or out of a medical setting. Devices can be in a number of form factors, ranging from wristbands and chest straps to patches and digestibles, and can be used by patients who suffer from a medical issue. Devices include blood pressure monitors, pulse oximeters, and fatigue monitors.
Patient-monitoring wearables are healthcare certified and monitor a patient’s vitals, sending them to a gateway device, such as a smartphone, and then to the cloud. From here, a medical professional accesses the information, allowing them to make treatment decisions and be alerted to any alterations in the patient’s health as they happen, meaning further issues can be prevented. Data from these devices can be automatically uploaded to the electronic medical record (EMR) directly, ensuring that a patient’s record is kept up to date. This allows all of the collected information to be used for any subsequent health issues, giving doctors the ability to see the patient’s full health history. The devices are usually prescribed to patients by their doctor. Reimbursement from medical providers or insurers is often available for these devices, depending on the patient and the type of device.
ABI Research categorizes these wearables into two overarching market segments: remote patient monitoring and on-site professional healthcare monitoring. Remote patient-monitoring wearables enable the monitoring of patients outside of conventional clinical settings (e.g. in the home), which help to extend access to care and decrease healthcare delivery costs. On-site professional healthcare monitoring wearables enable the monitoring of patients in a conventional clinical setting, such as a hospital or doctor’s office. These devices allow medical staff to constantly monitor the vitals of a number of patients within the hospital, alerting them to any issues that arise.
Owing to the COVID-19 pandemic, all industries, including healthcare, have had to embrace a move to digital to overcome the barriers created by the virus. We have seen a spike in digital health but the question is now how much of this change in behaviour will be temporary versus long-lasting, what emerging technologies and applications will drive this digital transformation, and whether there is a role for telecoms operators in this new landscape?
We interviewed Sharmila Devadoss, Founder and Managing Director at MedIoTek Health Systems and its platform VinCense – an Indian cloud-based patient monitoring platform, to understand her take on the digital health landscape, the role of new applications like remote patient monitoring, and how the telco could play a bigger part in the ecosystem. Below are some of the highlights from the discussion.
- What’s your view of the digital health market and what do you think are the key emerging application areas?
- How far along is the digital health market in achieving these objectives, and do you think that the impact of COVID-19 will be long lasting?
- How have you worked with the healthcare industry to implement patient monitoring use cases?
- What will be the role of emerging technologies like 5G and edge cloud in driving digital health?
- Who will be key partners for you in implementing these solutions?
- Is there a role for the telecoms operator beyond providing network connectivity?
Change is constant and, due to the COVID-19 pandemic, we have seen the most disruptive one in recent times. This seismic shift has seen hospitals being built in 100 days to meet the surge in demand and we are witnessing the adoption of telemedicine soar to heights never seen before – in the US we saw growth of 50 to 175 times overnight. According to McKinsey, $250 billion of America’s health care spend is likely to become “virtualized”.
We are about to witness an exponential improvement in healthcare delivery. Healthcare companies, large and small, are coming up with radical technological innovations. For example, GE Healthcare’s Edison platform is designed to help achieve greater efficiency, improve patient outcomes, and increase access to care – all based on AI.
It’s about driving the continuum of care – care from birth to death for all global citizens. This would be a dream come true for public health leaders and the right digital health ecosystem can definitely help achieve this going forward. We believe the time for digital health is here and now. Some of the key application areas emerging are:
- Virtual care (Remote Health Monitoring, Remote NCD Screening and Management)
- Precision Medicine
STL Partners covers these areas in detail in our recent article “What is digital health? 5 application areas telcos should focus on”
Currently, it is quite a fragmented market and digital health workflows lack standardisation. Interoperability, privacy and security are the major barriers to widespread adoption. To enable widespread adoption, key stakeholders need to collaborate and bring about the standardisation.
The ecosystem has to develop quickly to bring about the transformation in healthcare delivery and management. This is driven not only by COVID-19, but also by a surge in population and need to expand healthcare access, the shortage of healthcare professionals, and rapid advancements in telecommunication technology.
Considering that the pandemic is expected to continue for another 3 to 4 years, there is no alternative to virtual care. Patients are wary of going to hospitals and this is another key driver. Data driven healthcare delivery models make efficient virtual healthcare delivery feasible. In addition, it brings with it the advantage of lowered costs. So, we believe exponential growth is possible over the next 4 to 5 years in several parts of the world. The health-economy linkage will drive the adoption, as lives and livelihoods need to be saved.
Where does VinCense and patient monitoring fit into this changing landscape?
The VinCense platform is based on mobility, IoT, and analytics. It’s built around India’s first approved clinical grade wearable that tracks pulse rate, oxygen saturation, respiratory rate and skin temperature, and is well placed as an early mover in the wireless health monitoring space.
Our key differentiator is that our platform is capable of both automated continual monitoring and spot checks. It delivers live actionable data, through a sophisticated alerting mechanism with risk analytics to enable early intervention, leading to reduced risks and complications, thereby improving clinical outcomes.
Considering VinCense is the convergence of three transformative megatrends in IoT, cloud and big data, and its capability in delivering preventive and curative care virtually, we believe that we are well-poised to play a pivotal role in the digital health market.
We believe the key pain points that remote patient monitoring could address are shortage of frontline medical staff and physicians, elevated risk for healthcare professionals dealing with COVID-19 patients and, of course, shortage of health infrastructure. Non acute care delivery and the management of chronic/non-communicable diseases (NCDs) in particular would benefit.
In the case of India, the main customer base is hospitals and they are the payers. There is some home care play in which customers pay out of pocket, but the main opportunity for us is in B2B/B2B2X. In the case of the US, sweeping changes last April have facilitated coverage for telehealth under Medicaid and Medicare.
But, some of the key challenges working with hospitals are low levels of tech savviness, need for collaboration among stakeholders, lack of standards, and low levels of adoption of electronic health records (EHRs).
We intend to create a hybrid monitoring solution using 5G and AI/ML to provide advanced analytics using the edge. These technologies will have a multi-dimensional impact:
- Enable transformational new age healthcare delivery models driving healthcare for all (e.g. standardised workflows for various market segments, such as occupational health, public health, community health).
- Augment self-management of lifestyle diseases delivering improved access, convenience, and efficiency (e.g. connected devices platforms powered by AI can help individuals manage chronic diseases like diabetes, COPD and so on more effectively).
- Digital therapeutics will get a boost from VR platforms through virtual delivery of evidence-based behavioural treatments (e.g. treatment of burdensome diseases like schizophrenia, psychosis and other mental disorders, as well as chronic diseases).
- Hybrid remote monitoring, providing live, actionable data using multiple interfaces such as Wi-Fi, BLE, and OCC can lead to improved acute and sub-acute care (e.g. for patients in ICU and step down areas can be remotely monitored and the right combination of real time data and AI/ML algorithms will lead to improved patient outcomes).
STL Partners covers the role of 5G and edge computing in our recent articles “Digital health at the edge”, and “10 5G healthcare use cases transforming digital health”
The focus should be to build a strong ecosystem of stakeholders – from clinicians and practitioners, semiconductor companies, system integrators, telcos, medical device manufacturers, to health tech companies specialising in mobility, IoT, AI/ML, blockchain. Collaboration among the stakeholders will be the sure-fire way to sell into the healthcare industry.
Telecoms operators could provide hybrid remote health monitoring as a value-added service [on top of the network] for all households and particularly, senior citizens. Providing virtual preventive care could be pivotal.
Tie ups with, and helping to coordinate across, emergency services, insurance companies and local hospitals could be an added value proposition for the telco, too. Telcos that take the lead in forming formidable alliances with the right partners in spaces of healthcare delivery, insurance, pharmaceutical, diagnostics, telemedicine, health tech etc. will be able to capture a sizeable share in this blue ocean opportunity.
By combining connectivity and existing customer assets and coordinating across complex local and regional healthcare ecosystems, customised hyperlocal virtual healthcare for customers could become the norm – leading to health and wellbeing for all in the comfort and safety of their homes at affordable costs.
VinCense selected by Covid India Task force
YourStory Research Report on H1 2020 Startup Funding
VinCense associates with Chola MS Risk
Healthcare startup MedIoTek's IoMT device helps prescreen COVID-19 patients
Chennai-based healthcare startup MedIoTek Health Systems’ IoMT prescreening tool VinCense can identify and prioritise patients who need to take COVID-19 tests.
As India continues to maintain a lockdown to fight the coronavirus pandemic, the crisis is putting immense pressure on the country’s healthcare infrastructure. With an increasing number of COVID-19 cases, India is running out of PPEs, hazmat suits, masks, testing kits and facilities, ventilators, etc. to support the treatment of patients and safety of healthcare workers.
India’s huge population and limited medical resources mean conducting COVID-19 tests on the correct groups is critical. Chennai-based healthcare startup MedIoTek Health Systems aims to help with a coronavirus prescreening tool that helps prioritise sets of people who need the COVID-19 test.
Speaking to YourStory, Sharmila Devadoss, Founder and Managing Director at MedIoTek Health Systems, said B2B prescreening tool VinCense is an Internet of Medical Things (IoMT) platform that can screen major COVID-19 risk parameters such as the respiratory rate, skin temperature, oxygen saturation, pulse rate, and blood pressure in two minutes.
Apart from this, third-party devices such as glucometer, ECG etc. have also been integrated to monitor other conditions such as diabetes and hypertension, which are said to make people more vulnerable to COVID-19 . The device also provides the patient’s BMI and cardiovascular risk score.
“A single device can be used for screening many patients; it can be disinfected amid screenings. The monitoring feature is mainly targeted at high-risk individuals and/or bedridden patients,” Sharmila said.
How does VinCense work?
Sharmila explained that VinCense can be used for screening and monitoring of COVID-19 suspects. The idea is to identify people with symptoms and gauge if they could be infected with the coronavirus. However, the device does not confirm if a person is COVID-19 positive.
The wearable device screens risk factors such as respiratory rate, skin temperature, oxygen saturation, pulse rate, and blood pressure, and saves all data in the cloud. This can then be accessed via the VinCense mobile app. Depending on the readings, the device categorises patients in mild risk, moderate risk, moderate-severe risk, and severe risk categories.
According to Sharmila, patients who are “mild risk” might be asked to self-isolate themselves, while people under moderate risk and above are advised to take the COVID-19 test. This prescreening enables the healthcare sector prioritise COVID-19 tests in a more targeted manner, saving resources.
MedIoTek onboarded as digital partner in L&T infotech's IIoT platform
C-CIDA shortlists 13 near deployment-ready Covid-19 products
Bengaluru-based Centre for Cellular and Molecular Platforms’ (C-Camp) Covid-19 Innovations Deployment Accelerator or C-CIDA has shortlisted 13 near deployment-ready Covid-19 products across several categories.
C-CIDA has nominated 13 start-ups or ideas for impact in its second week round-up. The near deployment-ready Covid-19 products span critical categories such as ventilators, air and surface sanitisers which have tremendous potential for impact in India’s fight against Covid-19 pandemic.
The shortlisted start-ups are among C-CIDA’s prime candidates for industry and government support.
“Given the magnitude of the global health challenge that has been the Covid-19 pandemic, scope for importing solutions to address these outstanding needs becomes more and more unlikely. These indigenous innovations, that may have been gestating over the last 8 or 9 years are now emerging as solutions that are 1) timely 2) affordable and 3) effective,” said Taslimarif Saiyed, C-CAMP CEO and Director.
C-CIDA will now facilitate immediate uptake of these innovations by government and private sectors and scale up support wherever necessary. C-CIDA, was launched by C-CAMP on March 26. It had earlier selected five technologies as its first week stars. This latest batch of second week Stars come from an aggregate of over 740-plus submissions. Many more are expected to be announced in the coming weeks.
MedIoTek selected as Week 2 star in C-CAMP COVID-19 Deployment Accelerator (C-CIDA)
VinCense featured in leading Tamil News Channel Malai Murasu for its COVID19 risk screening capability
VinCense COVID-19 Risk Detection Use case covered in the Hindu, Apr 6, 2020
To address the issues such as lack of mass screening and data-driven methodology for COVID-19 risk detection, surveillance and management, VinCense, an Internet of Medical Things (ioMT)-based health screening and monitoring platform, has built the country’s first clinically-graded wearable, which can measure critical vitals such as pulse rate and respiratory rate in just two minutes.
here on Sunday, MedIoTek Health Systems Managing Director Sharmila Devadoss said it can record oxygen saturation and skin temperature, and 90 people can be screened in an hour and real time data would be made available for quick action.
The vitals would be transferred via low-energy Bluetooth to the mobile App from where they are sent to a secure cloud through Wi-Fi mobile data. Data analytics dashboards enable real-time surveillance and eases monitoring and evaluation. So quick decisions can be taken and lives saved.
Another feature is tracking the vitals of Covid-19 patients or other at-risk patients remotely, thus minimising workers’ risk and easing the load at hospitals.
Panel discussion on "Technology in Healthcare" at the CII TN Medclave 2021.
MoU with Velammal College of Engineering and Technology in Madurai.
Medtech Health check
VinCense partnership with Wipro GE Healthcare
The shortage of infrastructure and skilled healthcare professionals especially in rural India proved to be some of the weakest links in the Indian healthcare system as the country fought against COVID-19. Wipro GE Healthcare’s Remote Monitoring Solution, Tele-ICU, along with the Centricity High Acuity Critical Care Solution (CHA-CC) is tailor-made to connect Intensive Care Units (ICUs) in different locations or within the same building to central sites.
The technology has so far connected 800 beds across several hospitals in India to the hub hospital where highly skilled healthcare professionals can remotely provide advanced consultation and care to their critically ill patients. The hospitals which have deployed this solution include Apollo Hospitals-Hyderabad, Kainos Hospital-Rohtak and Apex Hospital-Jaipur. Currently, the ICU beds are connected from the States of Jharkhand, Assam, Maharashtra, Haryana, Andhra Pradesh, Odisha, Rajasthan and Madhya Pradesh.
Designed and developed in GE’s John F Welch Technology Center, Bangalore, Tele-ICU works on a hub and spoke model where it enables clinicians to provide a similar level of advanced consultation, care and monitoring to their critically ill patients without having to physically transfer them to a super‐specialty hospital.
Dr. Shailesh Jhawar, Chief Intensivist, Apex Hospital, Jaipur said, “Wipro GE Healthcare’s Tele-ICU solution has enhanced a healthcare professional’s capability to treat and consult more patients. From a mere 15 patients a day, now I am managing 80-100 patients, so it enhances the quality of the care that we are giving at least by four to five times.” After using the virtual care solution for six months, Dr Jhawar noticed that patients being treated at the spoke had improved clinical outcomes as well.
Additionally, Wipro GE Healthcare in partnership with MedIoTek (using CHA-CC and MedloTek’s wearable bands for monitoring of patient vitals) enabled 60 home beds to be connected to a central ICU of Saiman Healthcare in Delhi.
“Tele-ICU makes ICU care accessible to rural India and consolidates the efforts of intensivists. It is a smart way of managing and caring for patients across ICUs whether in a single hospital building or spread across locations,” said Amit Mohan, Head of Life Care & LCS Digital Solutions, Wipro GE Healthcare, South Asia.
Healthcare Warrior award 2021 at World Health & Wellness congress
VinCense one of the seven finalists in the Sweden India healthcare innovation challenge.
This report provides a comprehensive analysis of current global Real-Time Health Monitoring System market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Real-Time Health Monitoring System industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.
According to GRD Survey, the global Real-Time Health Monitoring System market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.
Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Real-Time Health Monitoring System Market Opportunties and Forecast 2022-2028 report makes a brilliant attempt to unveil key opportunities available in the global Real-Time Health Monitoring System market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.
The Global Real-Time Health Monitoring System Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Real-Time Health Monitoring System industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions
Segmented by Type
Bedside Health Monitoring System
Remote Health Monitoring System
Segmented by Application
Ambulatory Surgical Centers (ASCs)
Segmented by Country
Central & South America
Middle East & Africa
Key manufacturers included in this survey